Article Text

Download PDFPDF
Nerve Biopsy
  1. Lionel Ginsberg,
  2. Rosalind King,
  3. Richard Orrell
  1. University Department of Clinical Neurosciences, Royal Free Campus, Royal Free and University College Medical School, University College London, Rowland Hill Street, London, NW3 2PF, UK; Email: Lionel.Ginsberg{at}



It used to be said that a neurologist could diagnose the cause of a peripheral neuropathy in approximately 50% of cases on the basis of the history, examination and minimally invasive investigations – ‘screening’ blood and urine tests, chest X-ray, CSF examination and nerve conduction studies. About half the remainder would then be diagnosed by more specialized and invasive investigation, notably nerve biopsy, leaving approximately 25% of the original number cryptogenic. No doubt these proportions have changed with the increasing availability of specific DNA analysis for many of the genetic neuropathies, and the expanding range of serum autoantibodies associated with immunologically mediated neuropathies. Yet nerve biopsy remains an important diagnostic tool in patients with a progressive polyneuropathy of unknown aetiology, especially (but not exclusively) if asymmetrical. The emphasis on asymmetry (on clinical and/or electrical grounds) in this statement of the prime indication for nerve biopsy reflects the diagnosis most often

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.